Arthritis, Degenerative Clinical Trial
Official title:
A Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety and Efficacy of 3VM1001 Cream for the Treatment of Chronic Pain Caused by Osteoarthritis of the Knee: A Dose Ranging Study
A double-blind, placebo-controlled, randomized dose ranging study for the use of 3VM1001 Cream, 2g three times daily, 3g three times daily, or 3g four times daily for treatment of chronic pain associated with osteoarthritis of the knee compared to inactive placebo.
The study is a double-blind, placebo-controlled, dose ranging study for the use of 3VM1001
Cream, 2g three times daily, 3g three times daily, or 3g four times daily for the treatment
of chronic pain associated with osteoarthritis of the knee compared to the inactive vehicle
as a placebo.
A maximum of 120 subjects will be enrolled. Subjects will self-treat for 7 (+2) days, applied
in the morning and at bed time.
The active pharmaceutical ingredient is copper. The proposed doses in the study are less than
2% of the upper limit of the RDA (0.9 mg/day, upper limit 10mg/day).
Rescue medication is acetaminophen, up to ~2g daily (Up to six Tylenol Regular Strength
tablets).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04525950 -
Robotized Navigation Compared to Conventional Technique in Total Knee Replacement
|
N/A | |
Active, not recruiting |
NCT03312465 -
Anatomical Shoulder Domelock System Study
|
||
Recruiting |
NCT03260465 -
Clinical Study With the seleXys PC and the RM Pressfit Vitamys Cup
|
N/A | |
Active, not recruiting |
NCT02154516 -
Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement System
|
N/A | |
Completed |
NCT02784626 -
Intraoperative Sedatives and Postoperative Pain
|
Phase 4 | |
Completed |
NCT02967874 -
Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02341079 -
Intraoperative Liposomal Bupivacaine Injection in Primary Total Knee Arthroplasty
|
Phase 2/Phase 3 | |
Terminated |
NCT03245320 -
Clinical Evaluation of the TITAN™ Total Shoulder System
|
||
Recruiting |
NCT03958370 -
Validation of Consumer Activity Monitors in Postoperative Total Arthroplasty Patients
|
||
Recruiting |
NCT06080412 -
Blueprint® Mixed Reality Pilot Study
|
||
Active, not recruiting |
NCT03631030 -
Cooled RF Lesion MRI Characteristics
|
N/A | |
Withdrawn |
NCT02799654 -
Excia T Cementless EBRA Study
|
N/A | |
Completed |
NCT00105677 -
Understanding the Differences in the Management of Patients With Arthritis of the Knee or Hip
|
N/A | |
Terminated |
NCT02435420 -
A Retro-prospective Study of Total Hip Arthroplasty With EMPERION Modular Primary Stem in Australian Centres (HISTORIC)
|
N/A | |
Completed |
NCT02276833 -
Use of Autologous Adipose-Derived Stromal Vascular Fraction to Treat Osteoarthritis of the Knee
|
Phase 1 |